MillionMilesAway
Well-Known Member
Vague and possibly incorrect recollections follow:
Novavax haven't submitted final data and don't anticipate full scale production for a while (you need both production data and clinical trial data for approval).
J&J sumitted a couple of weeks earlier in the EU (it's normal for major markets to be prioritised) - UK approval imminent.
Yo're right about Novavax not having filed for approval yet.